Search This Blog

Tuesday, April 29, 2025

AstraZeneca ends trial for prostate cancer drug

 AstraZeneca (AZN) halts Truqap trial for prostate cancer after an independent review finds it unlikely to meet survival or progression goals

https://seekingalpha.com/news/4436917-astrazeneca-discontinues-truqap-trial-in-castration-resistant-prostate-cancer

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.